Noom Med vs Hims 2026: GLP-1 Weight Loss Programs Compared
Noom Med vs Hims for GLP-1 weight loss in 2026, compare pricing, coaching models, medication options, and clinical outcomes to find the right provider.
Written by Trimi Medical Team
Medically reviewed by Dr. Sean Arora, MD
Last updated 2026-04-08
More on GLP-1 Provider Comparisons
Noom Med vs Hims: Coaching Bundle vs Medication-First Platform
If you are searching for noom vs hims weight loss options, you are comparing two fundamentally different approaches to GLP-1 therapy. Noom Med bundles its well-known behavioral coaching app with prescription semaglutide, positioning the medication as one piece of a larger habit-change program. Hims bills its membership separately from medication; check its current program and support options. Noom Med charges more than providers like Trimi that focus exclusively on affordable, clinically supervised GLP-1 access.
Noom Med vs Hims, defined: Noom Med is a prescription weight loss program that pairs compounded semaglutide ($149 to $209 per month) with Noom's behavioral psychology-based coaching app (which may cost an additional $32 to $70 per month). Hims is a telehealth platform. In a March 2026 announcement, Hims said it would no longer advertise compounded GLP-1 offerings, and in March and April 2026 announcements it said its providers can prescribe Wegovy and Ozempic and send prescriptions for Zepbound (brand-name tirzepatide) to the LillyDirect pharmacy. Both are legitimate telehealth providers, but their philosophies, pricing structures, and value propositions differ significantly. For a closer look at Noom Med's credentials specifically, our is Noom Med legit review examines its providers, pharmacies, and what patient reviews report.
The clinical evidence behind brand-name GLP-1 medications is strong. The STEP 1 trial demonstrated that semaglutide 2.4 mg produced a mean body weight loss of 14.9% over 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SURMOUNT-1 trial showed tirzepatide at the highest dose achieved 20.9% body weight reduction over 72 weeks (Jastreboff et al., NEJM, 2022). Both trials studied the FDA-approved products; the compounded preparations prescribed through telehealth platforms are not FDA-approved and have not been studied in trials of their own.
Key Takeaway
Noom Med and Hims represent two different philosophies: coaching-plus-medication versus medication-first. Noom Med charges a premium compared to focused providers. Trimi offers semaglutide at $99/mo and tirzepatide at $125/mo on the annual plan (12-month commitment) with no app fees, no coaching markup, and no membership fee. See our cheapest GLP-1 guide for the full pricing landscape.
Noom Med vs Hims vs Trimi: Side-by-Side Comparison
The following table compares all three providers across the factors that matter most when choosing a GLP-1 weight loss program: cost, medication options, clinical support, and program model.
| Feature | Noom Med | Hims | Trimi |
|---|---|---|---|
| Semaglutide cost | $149-$209/mo | Membership plus separately billed brand-name medication | $99/mo |
| Tirzepatide cost | Not widely available | Zepbound via LillyDirect, billed separately from membership | $125/mo |
| Separate app/coaching fee | $32-$70/mo possible | None | None |
| Total monthly cost (semaglutide) | $149-$279/mo | Membership plus separately billed brand-name medication | $99/mo |
| Behavioral coaching | App-based CBT coaching | Not included | Clinical guidance |
| Daily lessons / habit tracking | Yes (via Noom app) | No | No |
| Contract commitment | Varies by plan | Monthly membership that auto-renews (March 2026 announcement) | $99/$125 annual plan is a 12-month commitment; month-to-month available at $175/$235 |
| Provider specialization | Behavioral health + weight loss | Multi-category telehealth | Metabolic health specialist |
| Medication included in price | Yes (app fee may be separate) | No (membership and medication billed separately) | Yes |
| Time to start medication | Days to weeks | See Hims' current pages | Days |
| 12-month total (semaglutide) | $1,788-$3,348 | Varies by medication; see Hims' pricing page | $1,188 |
| Best for | Patients who want coaching alongside medication | Simple, medication-focused GLP-1 access | Flat-priced compounded GLP-1 care (not FDA-approved) |
Pricing Analysis: What You Actually Pay at Noom Med vs Hims
Understanding the true cost of Noom Med versus Hims requires looking beyond the headline medication price. Noom Med's pricing structure includes a potential secondary cost layer, and Hims bills its membership separately from medication, which can make direct comparisons misleading if you only look at the base medication fee.
Noom Med Pricing
Noom Med charges $149 to $209 per month for compounded semaglutide, depending on the dosage tier. This price covers the medication and basic provider oversight. However, the Noom behavioral coaching app that makes Noom Med distinctive is not always included in the medication price. Depending on your plan structure, the coaching app can cost an additional $32 to $70 per month. This means a Noom Med patient who wants both the medication and the full coaching experience could pay $181 to $279 per month total. Over twelve months, that ranges from $1,788 to $3,348 annually for semaglutide alone. Patients curious about potential issues should review our Noom Med side effects guide.
Hims Pricing
In a March 2026 announcement, Hims listed its Weight Loss Membership at $39 for the first month, then auto-renewing at $149 per month, billed separately from medication, and said medication is not available without a membership. In the same announcement, Hims said it would no longer advertise compounded GLP-1 offerings; its August 2026 earnings release says it offers access to branded GLP-1 medications and to compounded GLP-1 medications on a limited scale. We could not confirm Hims' per-medication prices on hims.com in October 2026, so check Hims' current weight-loss pricing page for medication costs. For detailed information on what to expect, see our Hims weight loss side effects guide.
Annual Cost Comparison
Twelve months on semaglutide: Noom Med costs $1,788-$3,348 (with coaching app) and Trimi costs $1,188. The difference between Noom Med at its highest tier and Trimi is over $2,100 per year. For a complete breakdown of affordable options, see our cheapest GLP-1 injections guide.
Why the Coaching App Adds Cost Without Changing Medication Efficacy
The fundamental question when evaluating Noom Med's pricing is whether the bundled coaching app changes your weight loss outcomes enough to justify paying $50 to $150 more per month than a focused provider. The medication itself works through direct pharmacological mechanisms: GLP-1 receptor activation suppresses appetite, slows gastric emptying, and modulates central nervous system hunger signaling. None of these mechanisms are enhanced or diminished by whether you complete daily coaching lessons in an app. The coaching may support long-term behavioral habits, but it does not make the semaglutide injection more effective.
The Coaching Debate: Is Noom's App Worth Paying For?
Noom built its reputation on a behavioral coaching app grounded in cognitive behavioral therapy principles. The app delivers daily lessons, food logging tools, habit tracking, and personalized coaching messages designed to help users understand their eating patterns and build sustainable behaviors. When Noom added prescription GLP-1 medication through Noom Med, it positioned the program as a comprehensive solution combining pharmacology with behavioral psychology. This is Noom Med's core value proposition and the primary justification for its pricing premium.
Check Hims' current consultation, follow-up and behavioral-support options. In March 2026, Hims described membership billed separately from medication.
The research on this question is nuanced. Wadden et al. studied the effect of adding intensive behavioral therapy to semaglutide treatment and found that behavioral intervention produced modestly greater weight loss than medication with standard care alone. However, the incremental benefit of behavioral therapy was substantially smaller than the difference between semaglutide and placebo (JAMA, 2021). This finding suggests that while behavioral support can add value, the medication itself is the primary driver of weight loss outcomes, and the coaching component is supplementary rather than essential.
An important practical consideration: you do not need to bundle coaching and medication from the same provider. Patients who want behavioral support can subscribe to Noom's standalone coaching app (or any other habit-tracking app) while getting their GLP-1 medication from a more affordable provider like Trimi. This decoupled approach often costs less than Noom Med's bundled program while giving you the same tools and the same medication.
The Decoupling Strategy
Get your GLP-1 medication from a specialized, affordable provider and subscribe to any coaching or habit-tracking app separately. A Noom app subscription ($32-$70/mo) plus Trimi semaglutide ($99/mo) totals $131-$169 per month, which can be less than Noom Med's bundled pricing. You get the same coaching, the same medication, and more flexibility.
Clinical Evidence: What the Trials Show
Semaglutide and tirzepatide produce weight loss through direct pharmacological action on GLP-1 receptors (and GIP receptors in the case of tirzepatide). The trials below studied the FDA-approved brand-name products; compounded preparations, including those prescribed through Noom Med, are not FDA-approved and have not been studied in trials of their own.
The landmark STEP 1 trial enrolled 1,961 adults with obesity or overweight and demonstrated that semaglutide 2.4 mg weekly produced a mean body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo. Participants receiving semaglutide also showed clinically meaningful improvements in waist circumference, systolic blood pressure, and glycated hemoglobin (Wilding et al., New England Journal of Medicine, 2021).
The SURMOUNT-1 trial enrolled 2,539 adults and showed that tirzepatide at the highest dose (15 mg weekly) produced 22.5% mean body weight loss over 72 weeks, with 63% of participants achieving at least 20% body weight reduction (Jastreboff et al., New England Journal of Medicine, 2022). These results established tirzepatide as the most effective GLP-1-class therapy currently available. Notably, Hims offers tirzepatide while Noom Med's availability of tirzepatide remains limited, which is a meaningful distinction for patients seeking the more effective dual-agonist medication.
In the STEP 3 trial, Wadden et al. compared semaglutide with placebo, both alongside intensive behavioral therapy (JAMA, 2021). This design does not isolate the added benefit of coaching versus standard care or establish the value of Noom Med versus Hims. Discuss support needs with your clinician.
Evidence Summary
Semaglutide: 14.9% body weight loss over 68 weeks (STEP 1, Wilding et al., 2021). Tirzepatide: up to 20.9% body weight loss over 72 weeks (SURMOUNT-1, Jastreboff et al., 2022). Behavioral therapy adds modest incremental benefit on top of medication (Wadden et al., JAMA, 2021). In these trials, the medication, not the counseling, was the primary driver of outcomes. Learn more on our semaglutide and tirzepatide treatment pages.
Pros and Cons: Noom Med vs Hims
Noom Med: Strengths
Established behavioral coaching app built on cognitive behavioral therapy with years of development
Daily lessons, habit tracking, and food logging tools that promote long-term behavioral change
Integrated experience where coaching content and medication management live in one ecosystem
Strong user engagement model designed by behavioral psychologists
May help patients who need structured accountability beyond medication alone
Noom Med: Limitations
Total cost including the coaching app can reach $181 to $279 per month, significantly more than focused medication providers
Coaching app fee may be charged separately from the medication fee, creating confusing pricing
Behavioral coaching does not change the pharmacological efficacy of the GLP-1 medication
Tirzepatide availability is limited compared to platforms like Hims and Trimi
Cancellation terms vary by plan and some subscriptions auto-renew
The same coaching app can be purchased independently for less without the bundled medication markup
Hims: Strengths
In March 2026, Hims said membership and medication are billed separately, allowing for HSA or FSA reimbursement (eligibility varies by plan provider)
Both semaglutide and tirzepatide available, giving patients access to the most effective GLP-1 options
Monthly membership that auto-renews (March 2026 announcement)
Established telehealth infrastructure with a polished app experience
Hims: Limitations
Check current behavioral-support options with Hims
Check current consultation and follow-up options with Hims
Ask about the weight-management experience of the clinician assigned to you
Membership fee is billed on top of medication, and Hims' per-medication prices could not be confirmed on hims.com in October 2026
Ask how dose adjustments and side effects are managed
The Bottom Line: Choosing Between Noom Med, Hims, and Trimi
The right choice depends on how much value you place on behavioral coaching, how you prefer to structure your weight loss journey, and what you are willing to pay each month.
Choose Noom Med if you thrive with app-based coaching and will actively use it
Noom Med makes sense for patients who genuinely engage with daily lessons, food logging, and behavioral coaching modules. The app is one of the most sophisticated behavior-change tools available and has real value for people who use it consistently. However, the premium is only worth paying if you will use the coaching features regularly. If you subscribe and skip the daily content, you are paying extra for nothing. For step-by-step switching instructions if it is not for you, see our guide to canceling Noom Med.
Consider Hims if its current medication and support options suit your needs
Hims is a solid choice for self-directed patients who want FDA-approved brand-name GLP-1s such as Wegovy, Ozempic or Zepbound with a monthly membership that auto-renews. Hims bills its membership separately from medication, so check Hims' current pricing page for the full cost, and ask about its clinical support for your medical needs. See our guide on switching from Hims if you want to explore alternatives.
Choose Trimi for flat-priced compounded GLP-1 therapy with clinical supervision
Trimi offers compounded semaglutide at $99 per month and tirzepatide at $125 per month on the annual plan, a 12-month commitment (compounded medications are not FDA-approved), with licensed provider oversight, no membership fee, and no supplementary fees. For patients who are primarily seeking effective, affordable medication with competent clinical supervision, Trimi saves $600 to $2,100 or more per year compared to Noom Med. Patients who want behavioral coaching can pair Trimi with any coaching app of their choice for a customized, cost-effective approach.
GLP-1 medications are a long-term treatment. Most patients take them for twelve months or longer to achieve and sustain meaningful weight loss results. The financial difference between providers compounds over time: Noom Med at its highest tier costs over $2,100 more per year than Trimi. Choosing a provider you can afford to stay with long enough for the medication to work is one of the most important decisions in your weight loss journey. Start with Trimi's free assessment to see if you qualify.
The smartest approach may be to separate your medication management from your behavioral tools. Get your GLP-1 prescription from the most affordable, clinically sound provider you can find, and invest in whatever coaching, therapy, or habit-tracking tools work for you independently. This gives you maximum flexibility, the best price on medication, and the freedom to change your behavioral support without disrupting your treatment. For cancellation guides if you are currently with either provider, see our Noom Med cancellation guide and Hims cancellation guide.
Frequently Asked Questions
Is Noom Med or Hims better for GLP-1 weight loss?
It depends on what you value. Noom Med bundles its behavioral coaching app with GLP-1 medication, which suits patients who want structured habit-building alongside their prescription. Check Hims' current program and support options; in March and April 2026 announcements, Hims said its providers can prescribe FDA-approved brand-name GLP-1s such as Wegovy and Ozempic and send Zepbound prescriptions to the LillyDirect pharmacy. Trimi offers compounded semaglutide, which is not FDA-approved, at $99 per month on the annual plan, a 12-month commitment, with no coaching markup.
How much does Noom Med cost compared to Hims?
Noom Med charges $149 to $209 per month for semaglutide, and the Noom behavioral coaching app may cost an additional $32 to $70 per month depending on your plan. Hims bills its weight-loss membership separately from medication, and we could not confirm Hims' per-medication prices on hims.com in October 2026; check Hims' current pricing page. Trimi offers semaglutide at $99 per month and tirzepatide at $125 per month on the annual plan, a 12-month commitment, with no separate app fees.
Does Noom's coaching app actually improve GLP-1 weight loss results?
Noom's behavioral coaching app is based on cognitive behavioral therapy principles and can help patients build sustainable habits. However, research shows that the medication is the dominant driver of weight loss outcomes. Wadden et al. found that adding intensive behavioral therapy to semaglutide produced only modestly greater weight loss than medication with standard care (JAMA, 2021). The coaching may support long-term habit formation, but it does not change the pharmacological efficacy of GLP-1 medications.
Can I use Noom's app separately from my GLP-1 provider?
Yes. You can subscribe to Noom's behavioral coaching app independently and get your GLP-1 medication from a separate provider like Trimi. This approach lets you access Noom's habit-building tools while getting medication at a lower cost. The Noom app subscription is significantly cheaper on its own than the bundled Noom Med program.
Does Hims offer tirzepatide? Does Noom Med?
Yes. In March and April 2026 announcements, Hims said its providers can prescribe Wegovy and Ozempic and can send prescriptions for Zepbound (tirzepatide) to the LillyDirect pharmacy; in its August 2026 earnings release, Hims said it offers access to compounded GLP-1 medications on a limited scale. As of early 2026, Noom Med's GLP-1 program primarily focuses on semaglutide. Trimi offers compounded semaglutide at $99 per month and compounded tirzepatide at $125 per month on the annual plan, a 12-month commitment; compounded preparations are not FDA-approved.
What happens if I want to cancel Noom Med or Hims?
In a March 2026 announcement, Hims listed its Weight Loss Membership as auto-renewing monthly after the first month; check Hims' current terms before you cancel. Noom Med cancellation terms vary by plan, and some subscriptions auto-renew or have specific cancellation windows. Review your plan terms carefully. See our guides on canceling Noom Med and canceling Hims for step-by-step instructions.
How do Noom Med, Hims and Trimi compare on cost?
Trimi charges $99 per month for semaglutide and $125 per month for tirzepatide on the annual plan, a 12-month commitment, with no membership fee or app fees; Trimi's compounded preparations are not FDA-approved. Hims bills its membership separately from medication, and in March and April 2026 announcements Hims said its providers can prescribe FDA-approved brand-name GLP-1s. Noom Med's total cost including the coaching app ranges from $149 to $279 per month. Because the products differ, the choice depends on which medication you want and whether bundled coaching justifies the price premium.
Sources & References
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine, 2021;384(11):989-1002.
- Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine, 2022;387(4):327-340.
- Wadden TA, et al. "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity." JAMA, 2021;325(14):1403-1413.
- Noom, Inc. Noom Med official pricing and program information. 2026.
- Hims & Hers Health, Inc. Official pricing and program information. 2026.
- Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.
- FDA compounding regulation overview.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Pricing and program details are approximate, based on publicly available information as of April 2026, and subject to change. Verify current pricing directly with each provider. This article was prepared by the Trimi Medical Team and reviewed by Dr. Sean Arora, MD. Trimi is a competing provider; this comparison is presented fairly but readers should independently verify all claims.